PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer-Reference-Cited by-同舟云学术

PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer

Published:2015-04 Issue:2 Volume:10 Page:197-205
ISSN:1556-8598
Container-title:PET Clinics
language:en
Short-container-title:PET Clinics

Author:

Kwee Robert M.,Marcus Charles,Sheikhbahaei Sara,Subramaniam Rathan M.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiation

Reference52 articles.

1. Hibernomas show intense accumulation of FDG positron emission tomography;Tsuchiya;J Comput Assist Tomogr,2006

2. Howlader N, Noone A,M Krapcho M, et al, editors. SEER cancer statistics review, 1975–2011. Bethesda (MD): National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2011/. Accessed October 29, 2014.

3. Cancer statistics;Siegel;CA Cancer J Clin,2014

4. Esophageal cancer;Enzinger;N Engl J Med,2003

5. Recent developments in esophageal adenocarcinoma;Lagergren;CA Cancer J Clin,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measuring distance from the incisors to the esophageal cancer by FDG PET/CT: endoscopy as the reference;BMC Gastroenterology;2022-03-17

2. PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study;Therapeutic Advances in Medical Oncology;2021-01

3. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS;Annals of Oncology;2019-01

4. ESOPHAGEAL SQUAMOUS CELL CARCINOMA;INDO AM J PHARM SCI;2019

5. How to use PET/CT in the evaluation of response to radiotherapy;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2018-05